When the landmark analysis was applied assuming higher population incidences, only the overall association between BRCA2 mutations and PCa risk remained significant (SIR 2.30, 95% CI 1.47–3.60; Table 5). This evidence concerns the gene BRCA2 and posterior cortical atrophy.